As of Aug 26
| -0.195 / -0.63%|
The 28 analysts offering 12-month price forecasts for Roche have a median target of 38.17, with a high estimate of 47.15 and a low estimate of 30.89. The median estimate represents a +23.97% increase from the last price of 30.79.
The current consensus among 29 polled investment analysts is to Buy stock in Roche. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.